Article in Clinical journal of the American Society of Nephrology : CJASN, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
4 authors at 2 institutions in 1 country.
Earle C ChambersDepartment of Family and Social Medicine, Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0002-1323-0556
Keith C NorrisDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, California.ORCID 0000-0003-3071-0700
Samantha R LevanoDepartment of Family and Social Medicine, Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0001-9761-2596
Ladan GolestanehNephrology Division, Department of Medicine Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0003-1848-582
Albert Einstein College of Medicine · USUniversity of California, Los Angeles · US
Funding
UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
The Center for Health Improvement of Minority ElderlyP30AG021684 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Homero Erwin del Pino · 2002 to 2026
$19.7M
UCLA-UCI Center for Eliminating Cardio-Metabolic Disparities in Multi-Ethnic Populations (UC END-DISPARITIES)P50MD017366 · NIMHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BODEN-ALBALA, BERNADETTE MARIE, BROWN, ARLEEN F. · 2021 to 2025
$17.3M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
Power-Up Study Administrative Supplement to Promote DiversityR01DK121896 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CHAMBERS, EARLE C, GONZALEZ, JEFFREY S · 2019 to 2023
$3.6M
Peer mentorship to improve outcomes in patients on maintenance hemodialysisR18DK118471 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CAVANAUGH, KERRI, GOLESTANEH, LADAN · 2018 to 2020
$1.6M
Multidisciplinary electronic consultation to improve evidence-based care for patients with diabetic kidney diseaseR03HS028877 · AHRQ · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI GOLESTANEH, LADAN, RIKIN, SHARON · 2022 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Extreme Heat Can Exacerbate Disproportionate Burden of Severe Kidney Disease in Historically Marginalized Communities: Call to Action. · full record | OpenQuestion